Transdermal Drug Delivery Systems Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Fentanyl
1.2.3 Nitroglycerin
1.2.4 Estradiol
1.2.5 Nicotine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Transdermal Drug Delivery Systems Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 OTC
1.3.3 Rx
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Drug Delivery Systems Market Perspective (2018-2029)
2.2 Transdermal Drug Delivery Systems Growth Trends by Region
2.2.1 Transdermal Drug Delivery Systems Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Transdermal Drug Delivery Systems Historic Market Size by Region (2018-2023)
2.2.3 Transdermal Drug Delivery Systems Forecasted Market Size by Region (2024-2029)
2.3 Transdermal Drug Delivery Systems Market Dynamics
2.3.1 Transdermal Drug Delivery Systems Industry Trends
2.3.2 Transdermal Drug Delivery Systems Market Drivers
2.3.3 Transdermal Drug Delivery Systems Market Challenges
2.3.4 Transdermal Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Drug Delivery Systems Players by Revenue
3.1.1 Global Top Transdermal Drug Delivery Systems Players by Revenue (2018-2023)
3.1.2 Global Transdermal Drug Delivery Systems Revenue Market Share by Players (2018-2023)
3.2 Global Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transdermal Drug Delivery Systems Revenue
3.4 Global Transdermal Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Transdermal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery Systems Revenue in 2022
3.5 Transdermal Drug Delivery Systems Key Players Head office and Area Served
3.6 Key Players Transdermal Drug Delivery Systems Product Solution and Service
3.7 Date of Enter into Transdermal Drug Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal Drug Delivery Systems Breakdown Data by Type
4.1 Global Transdermal Drug Delivery Systems Historic Market Size by Type (2018-2023)
4.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2024-2029)
5 Transdermal Drug Delivery Systems Breakdown Data by Application
5.1 Global Transdermal Drug Delivery Systems Historic Market Size by Application (2018-2023)
5.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Transdermal Drug Delivery Systems Market Size (2018-2029)
6.2 North America Transdermal Drug Delivery Systems Market Size by Country (2018-2023)
6.3 North America Transdermal Drug Delivery Systems Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Transdermal Drug Delivery Systems Market Size (2018-2029)
7.2 Europe Transdermal Drug Delivery Systems Market Size by Country (2018-2023)
7.3 Europe Transdermal Drug Delivery Systems Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size (2018-2029)
8.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Country (2018-2023)
8.3 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Transdermal Drug Delivery Systems Market Size (2018-2029)
9.2 Latin America Transdermal Drug Delivery Systems Market Size by Country (2018-2023)
9.3 Latin America Transdermal Drug Delivery Systems Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size (2018-2029)
10.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2018-2023)
10.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Hisamitsu
11.1.1 Hisamitsu Company Detail
11.1.2 Hisamitsu Business Overview
11.1.3 Hisamitsu Transdermal Drug Delivery Systems Introduction
11.1.4 Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.1.5 Hisamitsu Recent Development
11.2 Mylan
11.2.1 Mylan Company Detail
11.2.2 Mylan Business Overview
11.2.3 Mylan Transdermal Drug Delivery Systems Introduction
11.2.4 Mylan Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.2.5 Mylan Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Transdermal Drug Delivery Systems Introduction
11.3.4 GSK Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Transdermal Drug Delivery Systems Introduction
11.4.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Teve (Actavis)
11.5.1 Teve (Actavis) Company Detail
11.5.2 Teve (Actavis) Business Overview
11.5.3 Teve (Actavis) Transdermal Drug Delivery Systems Introduction
11.5.4 Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.5.5 Teve (Actavis) Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Introduction
11.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Lohmann
11.7.1 Lohmann Company Detail
11.7.2 Lohmann Business Overview
11.7.3 Lohmann Transdermal Drug Delivery Systems Introduction
11.7.4 Lohmann Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.7.5 Lohmann Recent Development
11.8 Teikoku Seiyaku
11.8.1 Teikoku Seiyaku Company Detail
11.8.2 Teikoku Seiyaku Business Overview
11.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Introduction
11.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.8.5 Teikoku Seiyaku Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Transdermal Drug Delivery Systems Introduction
11.9.4 Bayer Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.9.5 Bayer Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Transdermal Drug Delivery Systems Introduction
11.10.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.10.5 Novartis Recent Development
11.11 Teve (Actavis)
11.11.1 Teve (Actavis) Company Detail
11.11.2 Teve (Actavis) Business Overview
11.11.3 Teve (Actavis) Transdermal Drug Delivery Systems Introduction
11.11.4 Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.11.5 Teve (Actavis) Recent Development
11.12 Qizheng
11.12.1 Qizheng Company Detail
11.12.2 Qizheng Business Overview
11.12.3 Qizheng Transdermal Drug Delivery Systems Introduction
11.12.4 Qizheng Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.12.5 Qizheng Recent Development
11.13 Endo
11.13.1 Endo Company Detail
11.13.2 Endo Business Overview
11.13.3 Endo Transdermal Drug Delivery Systems Introduction
11.13.4 Endo Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.13.5 Endo Recent Development
11.14 Huarun 999
11.14.1 Huarun 999 Company Detail
11.14.2 Huarun 999 Business Overview
11.14.3 Huarun 999 Transdermal Drug Delivery Systems Introduction
11.14.4 Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.14.5 Huarun 999 Recent Development
11.15 Haw Par
11.15.1 Haw Par Company Detail
11.15.2 Haw Par Business Overview
11.15.3 Haw Par Transdermal Drug Delivery Systems Introduction
11.15.4 Haw Par Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.15.5 Haw Par Recent Development
11.16 Nichiban
11.16.1 Nichiban Company Detail
11.16.2 Nichiban Business Overview
11.16.3 Nichiban Transdermal Drug Delivery Systems Introduction
11.16.4 Nichiban Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.16.5 Nichiban Recent Development
11.17 Mentholatum
11.17.1 Mentholatum Company Detail
11.17.2 Mentholatum Business Overview
11.17.3 Mentholatum Transdermal Drug Delivery Systems Introduction
11.17.4 Mentholatum Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.17.5 Mentholatum Recent Development
11.18 Laboratoires Genevrier
11.18.1 Laboratoires Genevrier Company Detail
11.18.2 Laboratoires Genevrier Business Overview
11.18.3 Laboratoires Genevrier Transdermal Drug Delivery Systems Introduction
11.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2018-2023)
11.18.5 Laboratoires Genevrier Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Fentanyl
Table 3. Key Players of Nitroglycerin
Table 4. Key Players of Estradiol
Table 5. Key Players of Nicotine
Table 6. Key Players of Other
Table 7. Global Transdermal Drug Delivery Systems Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Transdermal Drug Delivery Systems Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Transdermal Drug Delivery Systems Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Transdermal Drug Delivery Systems Market Share by Region (2018-2023)
Table 11. Global Transdermal Drug Delivery Systems Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Transdermal Drug Delivery Systems Market Share by Region (2024-2029)
Table 13. Transdermal Drug Delivery Systems Market Trends
Table 14. Transdermal Drug Delivery Systems Market Drivers
Table 15. Transdermal Drug Delivery Systems Market Challenges
Table 16. Transdermal Drug Delivery Systems Market Restraints
Table 17. Global Transdermal Drug Delivery Systems Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Transdermal Drug Delivery Systems Market Share by Players (2018-2023)
Table 19. Global Top Transdermal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery Systems as of 2022)
Table 20. Ranking of Global Top Transdermal Drug Delivery Systems Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Transdermal Drug Delivery Systems Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Transdermal Drug Delivery Systems Product Solution and Service
Table 24. Date of Enter into Transdermal Drug Delivery Systems Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Transdermal Drug Delivery Systems Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2018-2023)
Table 28. Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2024-2029)
Table 30. Global Transdermal Drug Delivery Systems Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Transdermal Drug Delivery Systems Revenue Market Share by Application (2018-2023)
Table 32. Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Transdermal Drug Delivery Systems Revenue Market Share by Application (2024-2029)
Table 34. North America Transdermal Drug Delivery Systems Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Transdermal Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Transdermal Drug Delivery Systems Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Transdermal Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Transdermal Drug Delivery Systems Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Transdermal Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2018-2023) & (US$ Million)
Table 43. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2024-2029) & (US$ Million)
Table 44. Hisamitsu Company Detail
Table 45. Hisamitsu Business Overview
Table 46. Hisamitsu Transdermal Drug Delivery Systems Product
Table 47. Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 48. Hisamitsu Recent Development
Table 49. Mylan Company Detail
Table 50. Mylan Business Overview
Table 51. Mylan Transdermal Drug Delivery Systems Product
Table 52. Mylan Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 53. Mylan Recent Development
Table 54. GSK Company Detail
Table 55. GSK Business Overview
Table 56. GSK Transdermal Drug Delivery Systems Product
Table 57. GSK Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 58. GSK Recent Development
Table 59. Novartis Company Detail
Table 60. Novartis Business Overview
Table 61. Novartis Transdermal Drug Delivery Systems Product
Table 62. Novartis Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Teve (Actavis) Company Detail
Table 65. Teve (Actavis) Business Overview
Table 66. Teve (Actavis) Transdermal Drug Delivery Systems Product
Table 67. Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 68. Teve (Actavis) Recent Development
Table 69. Johnson & Johnson Company Detail
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Transdermal Drug Delivery Systems Product
Table 72. Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Lohmann Company Detail
Table 75. Lohmann Business Overview
Table 76. Lohmann Transdermal Drug Delivery Systems Product
Table 77. Lohmann Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 78. Lohmann Recent Development
Table 79. Teikoku Seiyaku Company Detail
Table 80. Teikoku Seiyaku Business Overview
Table 81. Teikoku Seiyaku Transdermal Drug Delivery Systems Product
Table 82. Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 83. Teikoku Seiyaku Recent Development
Table 84. Bayer Company Detail
Table 85. Bayer Business Overview
Table 86. Bayer Transdermal Drug Delivery Systems Product
Table 87. Bayer Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 88. Bayer Recent Development
Table 89. Novartis Company Detail
Table 90. Novartis Business Overview
Table 91. Novartis Transdermal Drug Delivery Systems Product
Table 92. Novartis Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Teve (Actavis) Company Detail
Table 95. Teve (Actavis) Business Overview
Table 96. Teve (Actavis) Transdermal Drug Delivery SystemsProduct
Table 97. Teve (Actavis) Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 98. Teve (Actavis) Recent Development
Table 99. Qizheng Company Detail
Table 100. Qizheng Business Overview
Table 101. Qizheng Transdermal Drug Delivery SystemsProduct
Table 102. Qizheng Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 103. Qizheng Recent Development
Table 104. Endo Company Detail
Table 105. Endo Business Overview
Table 106. Endo Transdermal Drug Delivery SystemsProduct
Table 107. Endo Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 108. Endo Recent Development
Table 109. Huarun 999 Company Detail
Table 110. Huarun 999 Business Overview
Table 111. Huarun 999 Transdermal Drug Delivery SystemsProduct
Table 112. Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 113. Huarun 999 Recent Development
Table 114. Haw Par Company Detail
Table 115. Haw Par Business Overview
Table 116. Haw Par Transdermal Drug Delivery SystemsProduct
Table 117. Haw Par Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 118. Haw Par Recent Development
Table 119. Nichiban Company Detail
Table 120. Nichiban Business Overview
Table 121. Nichiban Transdermal Drug Delivery SystemsProduct
Table 122. Nichiban Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 123. Nichiban Recent Development
Table 124. Mentholatum Company Detail
Table 125. Mentholatum Business Overview
Table 126. Mentholatum Transdermal Drug Delivery SystemsProduct
Table 127. Mentholatum Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 128. Mentholatum Recent Development
Table 129. Laboratoires Genevrier Company Detail
Table 130. Laboratoires Genevrier Business Overview
Table 131. Laboratoires Genevrier Transdermal Drug Delivery SystemsProduct
Table 132. Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2018-2023) & (US$ Million)
Table 133. Laboratoires Genevrier Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transdermal Drug Delivery Systems Market Share by Type: 2022 VS 2029
Figure 2. Fentanyl Features
Figure 3. Nitroglycerin Features
Figure 4. Estradiol Features
Figure 5. Nicotine Features
Figure 6. Other Features
Figure 7. Global Transdermal Drug Delivery Systems Market Share by Application in 2022 & 2029
Figure 8. OTC Case Studies
Figure 9. Rx Case Studies
Figure 10. Transdermal Drug Delivery Systems Report Years Considered
Figure 11. Global Transdermal Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Transdermal Drug Delivery Systems Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Transdermal Drug Delivery Systems Market Share by Region: 2022 VS 2029
Figure 14. Global Transdermal Drug Delivery Systems Market Share by Players in 2022
Figure 15. Global Top Transdermal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery Systems as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery Systems Revenue in 2022
Figure 17. North America Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Transdermal Drug Delivery Systems Market Share by Country (2018-2029)
Figure 19. United States Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Transdermal Drug Delivery Systems Market Share by Country (2018-2029)
Figure 23. Germany Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Transdermal Drug Delivery Systems Market Share by Region (2018-2029)
Figure 31. China Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Transdermal Drug Delivery Systems Market Share by Country (2018-2029)
Figure 39. Mexico Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Transdermal Drug Delivery Systems Market Share by Country (2018-2029)
Figure 43. Turkey Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Transdermal Drug Delivery Systems Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 46. Mylan Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 47. GSK Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 49. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 50. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 51. Lohmann Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 52. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 53. Bayer Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 54. Novartis Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 55. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 56. Qizheng Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 57. Endo Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 58. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 59. Haw Par Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 60. Nichiban Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 61. Mentholatum Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 62. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Industry Market Size
